The largest database of trusted experimental protocols

17 protocols using lipofectamine 2000 agent

1

Generating Overexpression and Knockdown Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
TCF21 overexpression and knockdown was performed based on a modified protocol described previously [31 (link)]. Briefly, to establish the TCF21-expressing cell line, the cDNA encoding TCF21 (OriGene #SC12508) was cloned into the pWPI lentiviral backbone (#12254, Addgene, Inc. Cambridge, MA) to construct the transfer plasmid. Oligonucleotides encoding shTCF21 [31 (link)] and shDNMT1 [32 (link)] were inserted to the same plasmid. HEK293T cells (1 × 106) were seeded into tissue culture dish until 50% confluence. Transfection was done in DMEM medium, co-transfecting with packaging vectors and Mission Lentiviral packaging mix (Sigma-Aldrich) and Lipofectamine 2000 agent (Invitrogen). Virons that produced at 24 h-incubation were purified with centrifugation at 3000 rpm and filtration through a 0.45 μm-pore-size membrane. These virons were used to transfect cells cultured in 6-well plates. Cells stably expressing TCF21, shTCF21, or shDNMT1 were selected at 48 h after transfection using 2 μg/mL puromycin.
+ Open protocol
+ Expand
2

Investigating the lncRNA MDFIC-7 and miR-525-5p Regulatory Axis

Check if the same lab product or an alternative is used in the 5 most similar protocols
To examine the regulation between lncRNA MDFIC-7 and miR-525-5p, U-CH1 or U-CH2 cells were co-transfected with pmirGLO-MDFIC-7-WT, which contains the predicted miR-525-5p binding site, or pmirGLO-MDFIC-7-mut, together with miR-525-5p mimic, inhibitor or mock. To investigate the effect of lncRNA MDFIC-7 and miR-525-5p on ARF6, cells were co-transfected with pmirGLO-ARF6-3′UTR-WT and pmirGLO-ARF6-3′UTR-mut, together with miR-525-5p mimic or pcDNA-MDFIC-7. Transfection was performed using Lipofectamine 2000 agent (Invitrogen). After transfection for 48 h, the luciferase activity was calculated using the Dual-Luciferase Assay Kit (Promega) on a GloMax 20/20 Luminometer. Firefly luminescence was normalized to the Renilla luminescence according to the manufacturer’s instructions.
+ Open protocol
+ Expand
3

LINC02418 Regulation in Lung Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human LAD cell lines (A549, SPC-A1, H1299 and PC-9) and normal lung epithelial cells BEAS-2B were bought from the Cell Bank of the Chinese Academy of Sciences and incubated with Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen Life Technology Inc., Carlsbad, CA), containing 10% fetal bovine serum (FBS) with 5% CO2 at 37 °C in humid air. All cell lines were authenticated via STR profiling before using.
The suppression of LINC02418 expression was achieved by sh-LINC02418#1/2. Sh-LINC02418#1 and sh-LINC02418#2 were obtained from GenePharma (Shanghai, China). LINC02418 and KNL1 were overexpressed with pcDNA3.1 vectors (Invitrogen, Carlsbad, USA). MiR-4677-3p mimics were applied to elevate miR-4677-3p expression. MiR-4677-3p mimics and NC mimics were also bought from GenePharma (Shanghai, China). The transfection of above plasmids was conducted by use of Lipofectamine® 2000 agent (Invitrogen).
+ Open protocol
+ Expand
4

Modulating FOXM1 and Stathmin Expression in Gastric Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human FOXM1 expression vector pcDNA3.1-FOXM1, pcDNA3.1-Stathmin, siRNA-FOXM1, siRNA-Stathmin, siRNA-MCAK were obtained from the centre library of Affiliated Hospital of Qingdao University Medical College. For transfections, cells were seeded to a 40–50% confluence state and transfected with pcDNA3.1-FOXM1, pcDNA3.1-Stathmin, siRNA-FOXM1, siRNA-Stathmin, siRNA-MCAK, pcDNA3.1 or non-specific siRNA with Lipofectamine 2000 agent (Invitrogen, Carlsbad, CA, USA) in accordance with the manufacturer*s protocol. For the human Stathmin promoter plasmids containing firefly luciferase reporters, an internal control pMiniTK-RL, which included a full-length Renilla luciferase gene under the control of a minimal thymidine kinase promoter, was cotransfected into gastric tumour cell lines in triplicate. Twenty-four hours after transfection, cells were harvested for Luciferase assay.
+ Open protocol
+ Expand
5

Luciferase Assay for E-cadherin Promoter

Check if the same lab product or an alternative is used in the 5 most similar protocols
AGS, AGSR, MKN-74, and MKN-74R cells (1 × 105 cell/well) were seeded in a 6-well plate and transfected with 2 μg pGL2 luciferase vector (Promega, Madison, WI, USA) and reporter luciferase vector containing an E-cadherin promoter (−368~+51) after 24 hours using Lipofectamine 2000 agent (Invitrogen, Carlsbad, CA, USA). Luciferase activity was measured using a dual-luciferase reporter assay kit (Promega, Madison, WI, USA) on Molecular Devices Filter Max F3 (Molecular Devices, CA, USA). The luciferase activity was normalized to the activity of the Renilla luciferase.
+ Open protocol
+ Expand
6

Modulating NHE1 Expression in SGC7901 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
NHE1 expression vectors pcDNA3.1-NHE1 and siRNA-NHE1 were purchased from Genepharma (Shanghai). The pcDNA3.1-NHE1, siRNA-NHE1, pcDNA3.1 and non-specific siRNA were transfected to SGC7901 cells via Lipofectamine 2000 agent (Invitrogen, Carlsbad, CA, USA) in accordance with the manufacturer’s protocol. Forty-eight hours after transfection, fresh RPMI 1640 medium with 10% FBS was added. NHE1 inhibitor EIPA (25 μM, GLPBIO, CA, USA) was dissolved and stocked in DMSO and applied to the cells in the culture medium.
+ Open protocol
+ Expand
7

STC1 Full-Length Amplification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primer for STC1 full length amplication were synthesized with Hind III and EcoR I restriction enzymes sites. The forward primer was 5′-CCCAAGCTT ATGCTCCAAAACTCAGCAGTGCT-3′ (Hind III), and the reverse primer was 5′-CCGGAATTCTTATGCACTCTCATGGGATGTGC-3′ (EcoR I). HeLa and CaSki cells genomic DNA were used as the template. The purified PCR product was double–enzyme digested and ligated into the eukaryotic expression vector pcDNA3.1 (+). HeLa and CaSki cells were subject to transfection with specific plasmids by Lipofectamine 2000 agent (Invitrogen, Carlsbad, USA); pcDNA3.1 (+) vector was acted as control.
+ Open protocol
+ Expand
8

Modulating NEAT1, p65, and Galectin-3 Expressions

Check if the same lab product or an alternative is used in the 5 most similar protocols
The suppression of NEAT1 and p65 expression was achieved by transfection of si-NEAT1 or si-p65 (Genepharma, Shanghai, China) with Lipofectamine® 2000 agent (Invitrogen). A pcDNA3.1/p65 was used to overexpress p65 expression. Transfection of pcDNA3.1/Galectin-3 or pLVX/sh-Galectin-3 was performed to overexpressing or knocking down Galectin-3 (GeneCopoecia, Guangzhou, China).
+ Open protocol
+ Expand
9

Overexpression of SOX11 in CRC Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human CRC cell line SW480 (BNCC100604, BeNa culture collection, China) and COLO205 (ml039630, mlBio, China) were used from further investigations. All the cells were cultured in RPMI 1640 (Hyclone, USA) containing 10% fetal bovine serum (FBS) (Hangzhou Sijiqing Biotech, Co. Ltd. China) and 1% Penicillin/Streptomycin in a humidified 5% CO2 at 37°C. SOX11 expression vector pcDNA3.1 and pcDNA-SOX11 were purchased from the Genepharma, China. The pcDNA3.1 and pcDNA-SOX11 were transfected to SW480 and COLO205 via Lipofectamine 2000 agent (Invitrogen, Carlsbad, CA, USA) in accordance with the manufacturer's protocol. About 48 hr after transfection, fresh RPMI 1640 medium with 10% FBS was added.
+ Open protocol
+ Expand
10

E-cadherin Promoter Activity Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the E-cadherin promoter activity, AGS cells (2×105 cell/well) were seeded in a six-well plate and transfected with 2.5 μg of pGL2 luciferase vector (Promega) and reporter luciferase vector containing an E-cadherin promoter (-368~+51) after 24 h using Lipofectamine 2000 agent (Invitrogen). Luciferase activity was measured 36 h after transfection in three independent cultures using a dual-luciferase reporter assay kit (Promega) on Molecular Devices Filter Max F3 (Molecular Devices). The luciferase activity was normalized to activity of the Renilla luciferase.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!